By Sean Moloughney, Editor, Nutraceuticals World09.03.19
Few nutraceutical ingredients have burst onto the U.S. market quite like hemp and cannabidiol (CBD), which were propelled by the passage of the Agriculture Improvement Act of 2018 (also known as the Farm Bill). The regulation declassified hemp with less than 0.3% THC as a Schedule I controlled substance and legalized cultivation.
However, the U.S. Food and Drug Administration (FDA) continues to regulate cannabis products under the Food, Drug, and Cosmetic Act.
One of the many components of hemp and cannabis, CBD has been marketed as a panacea for modern living, in both topical and ingestible product formulations, drawing warning letters that have called out bogus health claims and the ire of more modest brands.
Given federal statute regarding investigational new drug trials that might preclude a New Dietary Ingredient (NDI) Notification, FDA has stated that CBD cannot legally be sold as a dietary supplement in the U.S. However, at the same time, it has mostly exercised enforce
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
